These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 36909105)
1. Determination of Factors Influencing the Health Belief Model (HBM) and Adherence to Intravitreal Anti-vascular Endothelial Growth Factor (VEGF) Among Patients With Diabetic Macular Edema (DME). Ting Yih Ling J; Mohd Zain A; Naffi AA; Mustapha M; Wan Abdul Halim WH Cureus; 2023 Feb; 15(2):e34669. PubMed ID: 36909105 [TBL] [Abstract][Full Text] [Related]
2. Adherence to Intravitreal Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Drugs in Diabetic Macular Edema in an Egyptian Population: A Health Belief Model. Habib AE; Abdel-Kader AA; Eissa IM; Awadein A Curr Eye Res; 2019 Mar; 44(3):303-310. PubMed ID: 30383436 [TBL] [Abstract][Full Text] [Related]
4. The psychological status of patients with delayed intravitreal injection for treatment of diabetic macular edema due to the COVID-19 pandemic. Zaini MA; Mohd Zain A; Din NM; Mustapha M; Sidi H PLoS One; 2023; 18(8):e0290260. PubMed ID: 37624864 [TBL] [Abstract][Full Text] [Related]
5. The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial. Mi X; Gu X; Yu X Trials; 2022 Sep; 23(1):736. PubMed ID: 36056443 [TBL] [Abstract][Full Text] [Related]
7. Different Anti-Vascular Endothelial Growth Factor for Patients With Diabetic Macular Edema: A Network Meta-Analysis. Wang X; He X; Qi F; Liu J; Wu J Front Pharmacol; 2022; 13():876386. PubMed ID: 35814207 [No Abstract] [Full Text] [Related]
8. Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice. Maloney MH; Schilz SR; Herrin J; Sangaralingham LR; Shah ND; Barkmeier AJ Ophthalmology; 2019 Jul; 126(7):1007-1015. PubMed ID: 30292542 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Clinical Practice of Single Center: Three-Year Outcomes. Choovuthayakorn J; Phinyo P; Tantraworasin A; Kunavisarut P; Patikulsila D; Chaikitmongkol V; Watanachai N; Pathanapitoon K Ophthalmic Res; 2021; 64(3):483-493. PubMed ID: 33053556 [TBL] [Abstract][Full Text] [Related]
10. Questionnaire for the assessment of adherence barriers of intravitreal therapy: the ABQ-IVT. Müller S; Junker S; Wilke T; Lommatzsch A; Schuster AK; Kaymak H; Ehlken C; Ziemssen F Int J Retina Vitreous; 2021 Jun; 7(1):43. PubMed ID: 34078475 [TBL] [Abstract][Full Text] [Related]
11. Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study. Wirkkala J; Kubin AM; Ohtonen P; Yliselä J; Siik T; Hautala N BMC Ophthalmol; 2022 Jun; 22(1):258. PubMed ID: 35681133 [TBL] [Abstract][Full Text] [Related]
12. Healthcare Utilization and Treatment Patterns in Diabetic Macular Edema in Korea: a Retrospective Chart Review. Park KH; Kim YY; Jo YJ; Oh J; Lee JE; Lee JE; Park DH; Kang SW; Lee WK; Kim HK; Adena M; Tan J; Kim SD J Korean Med Sci; 2019 Apr; 34(15):e118. PubMed ID: 31001935 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of Patients With Active Diabetic Macular Edema at the Time of Cataract Surgery Managed With Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Starr MR; Mahr MA; Smith WM; Iezzi R; Barkmeier AJ; Bakri SJ Am J Ophthalmol; 2021 Sep; 229():194-199. PubMed ID: 33852907 [TBL] [Abstract][Full Text] [Related]
14. COMPLIANCE AND ADHERENCE OF PATIENTS WITH DIABETIC MACULAR EDEMA TO INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN DAILY PRACTICE. Weiss M; Sim DA; Herold T; Schumann RG; Liegl R; Kern C; Kreutzer T; Schiefelbein J; Rottmann M; Priglinger S; KortUEm KU Retina; 2018 Dec; 38(12):2293-2300. PubMed ID: 29068914 [TBL] [Abstract][Full Text] [Related]
15. Atrophy of the central neuroretina in patients treated for diabetic macular edema. Karst SG; Schuster M; Mitsch C; Meyer EL; Kundi M; Scholda C; Schmidt-Erfurth UM Acta Ophthalmol; 2019 Dec; 97(8):e1054-e1061. PubMed ID: 31228332 [TBL] [Abstract][Full Text] [Related]